959-30-8 Usage
Description
[(amino-phenyl-methylidene)amino] benzoate is an organic compound characterized by a benzene ring attached to a carboxylate group and an amino group. It is recognized for its potential pharmacological properties and is commonly utilized in the fields of organic chemistry and pharmaceuticals. [(amino-phenyl-methylidene)amino] benzoate has garnered attention for its possible biological activities, such as anti-inflammatory and antioxidant effects, and its potential use in the synthesis of novel organic compounds with pharmaceutical applications. Its unique chemical structure and properties make it a valuable subject of interest for researchers aiming to develop new medications or materials with specific biological activities.
Uses
Used in Pharmaceutical Applications:
[(amino-phenyl-methylidene)amino] benzoate is used as a key component in the development of new pharmaceuticals for its potential pharmacological properties. Its anti-inflammatory and antioxidant effects make it a promising candidate for the treatment of various conditions, including inflammation-related diseases and oxidative stress-related disorders.
Used in Organic Chemistry:
In the field of organic chemistry, [(amino-phenyl-methylidene)amino] benzoate is used as a building block for the synthesis of novel organic compounds with potential pharmaceutical applications. Its unique structure allows for the creation of new molecules with specific biological activities, contributing to the advancement of drug discovery and development.
Used in Research and Development:
[(amino-phenyl-methylidene)amino] benzoate is employed as a subject of interest in research and development, particularly for scientists and researchers looking to explore its potential biological activities and applications. Its chemical structure and properties make it a valuable tool for understanding the mechanisms of various diseases and for developing targeted therapies and treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 959-30-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,5 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 959-30:
(5*9)+(4*5)+(3*9)+(2*3)+(1*0)=98
98 % 10 = 8
So 959-30-8 is a valid CAS Registry Number.
959-30-8Relevant articles and documents
Three N2-benzoyloxybenzamidines: Sheet structures built from hard and soft hydrogen bonds and aromatic π-π stacking interactions
Carvalho, Carlos E.M.,Wardell, Solange M.S.V.,Wardell, James L.,Skakle, Janet M.S.,Low, John N.,Glidewell, Christopher
, p. o28-o32 (2004)
The molecular structures of N2-(benzoyloxy)benzamidine, (I), N2-(2-hydroxybenzoloxy)benzamidine, (II), and N 2-benzoyloxy-2-hydroxy-benzamidine, (III), were analyzed. The molecules of (I) were linked into chains by a single N-H···N hydrogen bond and these chains were linked into sheets by aromatic π-π stacking interactions. The molecules of (I) and (III) had chain extended conformations, with the aryl groups remote from one another. It was observed that in these three compounds conformations were influenced by intermolecular hydrogen bonding involving the substituted aryl rings.
Formation and cyclization of N′-(benzoyloxy)benzenecarboximidamides
Tsiulin,Sosnina,Krasovskaya,Danilova,Baikov,Kofanov
experimental part, p. 1874 - 1877 (2012/03/22)
The formation of N′-(benzoyloxy)benzenecarboximidamides and their subsequent cyclization to 3,5-disubstituted 1,2,4-oxadiazoles in different solvents were studied. A probable reaction mechanism was proposed on the basis of the obtained results.
NOVEL O-ACYLOXIME DERIVATIVES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
-
Page/Page column 7-8, (2008/06/13)
The present invention relates to novel O-acyloxime derivatives, a preparation method thereof and a pharmaceutical composition comprising the same for prevention and treatment of cardiovascular disease. The O-acyloxime derivatives according to the present invention may valuably be used for prevention and treatment of cardiovascular diseases such as hyperlipidemia, coronary arterial heart disease, atherosclerosis, and myocardial infarction caused by Lp-PLA2, because they have excellent inhibitory effect of Lp-PLA2.
